Follicum became a partner in a large research project on diabetes during 2017
The Swedish Foundation for Strategic Research is funding different projects in life science and technology. Follicum was invited to participate in a diabetes project, headed by the University of Lund (LUDC-IRC). The funding is 100 MSEK (roughly 12 MUSD) over several years. Follicum is partnering with several large, commercial players in the project, like Novo Nordisk, Johnson & Johnson Innovation, Pfizer and others as well as the Region Skåne through the University Hospital of Malmö.
Our early work with the peptide FOL-014 has been noted by the Novo Nordisk Foundation. The foundation has granted 400 KDKK (roughly 45 KUSD) for continued pre-clinical trials and development of FOL-014.